Ticker Details
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology.
IPO Date:	June 9, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$17.81M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.07 | 4.34%
Avg Daily Range (30 D):	$0.05 | 4.77%
Avg Daily Range (90 D):	$0.06 | 4.66%

Institutional Daily Volume
Avg Daily Volume:	1.56M
Avg Daily Volume (30 D):	.88M
Avg Daily Volume (90 D):	.78M

Trade Size
Avg Trade Size (Sh.):	391
Avg Trade Size (Sh.) (30 D):	278
Avg Trade Size (Sh.) (90 D):	266

Institutional Trades
Total Institutional Trades:	45
Avg Institutional Trade:	$2.78M
Avg Institutional Trade (30 D):	$6.8M
Avg Institutional Trade (90 D):	$6.8M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$6.35M
Avg Closing Trade (30 D):	$6.8M
Avg Closing Trade (90 D):	$6.8M
Avg Closing Volume:	149.91K

News

Dec 24, 2025 @ 2:04 PM Stock Market Today: Dow Jones, Nasdaq Futures Slip... Source: Rishabh Mishra

Dec 10, 2025 @ 9:30 PM Citius Oncology Announces Closing of $18 Million C... Source: Prnewswire

Dec 9, 2025 @ 1:30 PM Citius Oncology Announces $18 Million Concurrent R... Source: Prnewswire

Sep 10, 2025 @ 8:30 PM Citius Oncology Announces Closing of $9.0 Million ... Source: Prnewswire

Sep 9, 2025 @ 12:30 PM Citius Oncology Announces Pricing of $9.0 Million ... Source: Prnewswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.38	$-.11	$-3.38
Diluted EPS	$-3.38	$-.11	$-3.38
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-39.74M	$-8.74M	$-39.74M
Operating Income / Loss	$-38.53M	$-8.44M	$-38.53M
Cost of Revenue
Net Cash Flow	$1M	$1M	$1M
PE Ratio

Splits
Nov 26, 2024	1:25
Jun 09, 2017	1:15
Sep 12, 2014	5:8